Mavacamten
id:
mavacamten-194-12496414
title:
Mavacamten
text:
Mavacamten, sold under the brand name Camzyos, is a medication used to treat obstructive hypertrophic cardiomyopathy. Mavacamten is a small-molecule allosteric and cardiac myosin inhibitor. It was developed by MyoKardia, a subsidiary of Bristol Myers Squibb. In clinical studies, mavacamten has demonstrated significant efficacy in reducing cardiac muscle contractility by targeting the sarcomere hypercontractility that is one of the characteristics of hypertrophic cardiomyopathy and inhibits exces
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Mavacamten
date created:
date modified:
2024-03-28T01:27:46Z
main entity:
{"identifier":"Q105337531","url":"https://www.wikidata.org/entity/Q105337531"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/aa/Mavacamten.svg","width":580,"height":365}
fields total:
13
integrity:
15